| Fairview Pharmacy Brooklyn Park | |
| 10000 Zane Ave N, Brooklyn Park, Minnesota 55443 | |
| (763) 569-6281 |
| Name | Fairview Pharmacy Brooklyn Park |
|---|---|
| Organization Name | Fairview Pharmacy Services Llc |
| Location | 10000 Zane Ave N, Brooklyn Park, Minnesota 55443 |
| Type | Non-Pharmacy Dispensing Site |
| Phone | (763) 569-6281 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.
Probiotics are live microorganisms intended to boost health, such as the bacteria in some yogurts. These are popular among the health conscious. One of probiotics' most popular uses is in preventing and treating digestive problems.
QLT Inc. today announced interim results from the first 3 subjects enrolled in a Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber congenital amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and significant visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.
According to new research from the University of Illinois at Chicago, about one in five children regularly use prescription medications, and nearly one in 12 of those children are at risk for experiencing a harmful drug-drug interaction.
› Verified 5 days ago
| NPI Number | 1629357918 |
| Organization Name | FAIRVIEW PHARMACY SERVICES LLC |
| Doing Business As | FAIRVIEW BROOKLYN PARK CLINIC MTM |
| Type | Non-Pharmacy Dispensing Site |
| Address | 10000 Zane Ave N, Brooklyn Park, MN 55443 |
| Phone Number | 763-572-5700 |
News Archive
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.
Probiotics are live microorganisms intended to boost health, such as the bacteria in some yogurts. These are popular among the health conscious. One of probiotics' most popular uses is in preventing and treating digestive problems.
QLT Inc. today announced interim results from the first 3 subjects enrolled in a Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber congenital amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and significant visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.
According to new research from the University of Illinois at Chicago, about one in five children regularly use prescription medications, and nearly one in 12 of those children are at risk for experiencing a harmful drug-drug interaction.
› Verified 5 days ago
| NPI Number | 1649370396 |
| Organization Name | COLUMBIA PARK MEDICAL GROUP, PA |
| Doing Business As | CPMG-BROOKLYN PARK PHARMACY |
| Type | Clinic Pharmacy |
| Address | 10000 Zane Ave N, Suite 100, Brooklyn Park, MN 55443 |
| Phone Number | 763-569-6281 |
News Archive
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.
Probiotics are live microorganisms intended to boost health, such as the bacteria in some yogurts. These are popular among the health conscious. One of probiotics' most popular uses is in preventing and treating digestive problems.
QLT Inc. today announced interim results from the first 3 subjects enrolled in a Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber congenital amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and significant visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.
According to new research from the University of Illinois at Chicago, about one in five children regularly use prescription medications, and nearly one in 12 of those children are at risk for experiencing a harmful drug-drug interaction.
› Verified 5 days ago
News Archive
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.
Probiotics are live microorganisms intended to boost health, such as the bacteria in some yogurts. These are popular among the health conscious. One of probiotics' most popular uses is in preventing and treating digestive problems.
QLT Inc. today announced interim results from the first 3 subjects enrolled in a Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber congenital amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and significant visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.
According to new research from the University of Illinois at Chicago, about one in five children regularly use prescription medications, and nearly one in 12 of those children are at risk for experiencing a harmful drug-drug interaction.
› Verified 5 days ago
Cvs Pharmacy #16213 Type: Community/Retail Pharmacy Location: 7535 W Broadway Ave, Brooklyn Park, Minnesota 55428 Phone: (763) 425-5300 | |
Cvs Pharmacy #11070 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4400 Oak Grove Parkway, Brooklyn Park, Minnesota 55443 Phone: (763) 315-1935 | |
Walmart Pharmacy 10-1864 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8000 Lakeland Ave N, Brooklyn Park, Minnesota 55445 Phone: (763) 424-7077 | |
Walgreens #2316 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2024 85th Ave N, Brooklyn Park, Minnesota 55444 Phone: (763) 424-9243 | |
Hy-vee Pharmacy (1040) Type: Community/Retail Pharmacy Location: 9409 Zane Ave N, Brooklyn Park, Minnesota 55443 Phone: (763) 488-4502 |